) (11.18) Net Profit (Loss) (43.62) (6.22) 37.40 601.29 Earnings per share (Baht per share) (0.008) (0.001) 0.007 700.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of

Expense 0.03 0.002% (0.75) (0.07%) (0.77) (103.62%) 4.36 0.31% 4.33 (99.38%) Net Profit (Loss) 82.41 5.44% 54.98 5.34% 27.42 49.88% 76.56 5.45% 5.85 7.64% Earnings per share (Baht per share) 0.016 0.011

expenses of the consolidated accounts in Q3/2017 was higher than last year at the same period mainly due to marketing expenses in advertising and presenter to motivate customer to use its services. SG&A as

share from the Company’s retained earnings to the shareholders whose name appear on the share register book on 9 May 2019 (Record Date). The dividend will be paid on 28 May 2019. 2) approved to acquire 49

were back on track with 44.5% growth YoY and 3.4% growth QoQ. - In Q1’19, the Company maintained its leadership position with total market share of 31.1% in Brain and Body Boost (“BBB”) products which

Company has net profit attributed to owners of the parent of 987 million baht or 3.95 baht per share, showing a record growth rate of 6% y-y and 21% q-q. The financial performance can be summarized as

Public Company Limited’s subsidiary company (“The Company”), Joint Venture Ureka UU co., ltd. (“UU”), in which the company hold 90% of the share. The company plans to increase the shareholding to 99%. On

of UWC’s investment in Power Plants business as UWC entered into Share Purchase Agreement with Absolute Clean Energy Plc. on July 10, 2020 in the total amount of THB 851.20 million even though this

68.6% Gross Profit 813 396 417 105.3% Gross Profit Margin (%) 11.1% 9.3% 1.8% SG&A Expenses 456 310 146 46.9% EBIT before share of profit (loss) from Investment in Associates and Joint Venture 608 275

previously recognised through comprehensive income 171.2 0.0 171.2 N/A EBIT before share of profit (loss) from investment in associates and joint venture 51.5 452.7 -401.1 -88.6% Share of profit (loss) from